Mint-Imatinib 400 mg

Mint-Imatinib 400 mg tablets are a pharmaceutical product containing imatinib mesylate, used for targeted therapy. This oral medication is designed to support specific treatment protocols as prescribed by healthcare professionals.

Mint-Imatinib 400 mg tablets are primarily used in the management of certain types of cancer. Imatinib mesylate, the active ingredient, is often utilized in targeted therapy to inhibit the growth of cancer cells. This medication is commonly prescribed for conditions where specific proteins are involved in the progression of the disease. Patients should consult their healthcare provider to understand what is imatinib used for in their specific case.

Common effects of Mint-Imatinib 400 mg tablets may include nausea, fatigue, and muscle cramps. Some individuals might experience swelling, rash, or changes in blood counts. It is important to monitor for any unusual symptoms and report them to a healthcare professional.

Mint-Imatinib 400 mg tablets should be handled with care, stored in a cool, dry place, and kept out of reach of children. Patients with liver or kidney issues should discuss their condition with a healthcare provider before starting this medication. Regular medical check-ups are recommended to monitor the effects of the treatment.

Mint-Imatinib 400 mg tablets may interact with certain medications, including those metabolized by the liver's cytochrome P450 enzymes. Patients should inform their healthcare provider about all medications they are taking, including over-the-counter drugs and supplements. Alcohol consumption should be discussed with a healthcare professional to avoid potential interactions.